HER 2 NEGATIVE BREAST CANCER

Clinical trials for HER 2 NEGATIVE BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HER 2 NEGATIVE BREAST CANCER trials appear

Sign up with your email to follow new studies for HER 2 NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New drug boosts chemo to fight breast cancer before surgery

Disease control Not yet recruiting

This study is testing whether adding an immunotherapy drug called eftilagimod alpha (Efti) to standard chemotherapy given before surgery can help eliminate more cancer in patients with early-stage, hormone-positive, HER2-negative breast cancer. The main goal is to see if this com…

Matched conditions: HER 2 NEGATIVE BREAST CANCER

Phase: PHASE2 • Sponsor: George Washington University • Aim: Disease control

Last updated Apr 01, 2026 14:40 UTC

HER 2 NEGATIVE BREAST CANCER

Get alerted when new HER 2 NEGATIVE BREAST CANCER trials appear

New drug boosts chemo to fight breast cancer before surgery